Pathological analyses of very long-term sirolimus-eluting stent implantation in human coronary artery

Masao Imai1, Takeshi Kimura1, Junichi Tazaki1

  • 1Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, 54 Shougoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.

Journal of Cardiology Cases
|December 12, 2018
PubMed

Insights

Autopsy of a sirolimus-eluting stent (SES) recipient revealed neoatherosclerosis, characterized by lipid accumulation around struts, despite minimal neointimal formation and no restenosis or thrombosis. Long-term follow-up is crucial after SES implantation.

Area of Science:

  • Cardiovascular Pathology
  • Interventional Cardiology
  • Biomaterials Science

Background:

  • Sirolimus-eluting stents (SES) are widely used for coronary artery disease.
  • Long-term histopathological data after SES implantation are limited.
  • Understanding late stent behavior is crucial for improving stent design.

Observation:

  • A 73-year-old male patient with coronary artery disease received SES in the LAD and LCX.
  • The patient died after 57 months due to unrelated causes.
  • Autopsy provided a unique opportunity for very-late-stage stent analysis.

Findings:

  • Histopathology showed mild neointimal formation with patent lumens and endothelial coverage in stented segments.
  • Significant findings included necrotic core formation with cholesterol clefts around stent struts, indicative of neoatherosclerosis.
  • No evidence of restenosis, neointimal rupture, or stent thrombosis was observed.

Implications:

  • Neoatherosclerosis, a late complication, can occur even with favorable short-term stent healing.
  • The findings highlight the need for further development of biocompatible drug-eluting stents to minimize arterial wall inflammation.
  • Close clinical monitoring is recommended for patients with long-term SES implantation.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
443
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
267
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
372
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
687
High-Performance Liquid Chromatography: Elution Process01:05

High-Performance Liquid Chromatography: Elution Process

In High-Performance Liquid Chromatography (HPLC), the elution process is critical to the separation of analytes and the quality of chromatographic results. Elution describes how compounds move through the column and separate based on their interactions with the mobile and stationary phases. This process determines the resolution, peak shape, and retention times in the chromatogram, which are essential for identifying and quantifying components in complex mixtures. Understanding the elution...
1.5K